Baxter International Inc
BAX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$86.00 | Zgzknt | Kwqdfcmm |
Supply Chain Pressures Roil Baxter's Near-Term Outlook; Shares Cheap Even After FVE Cut
While narrow-moat Baxter appeared to roughly meet expectations in the second quarter, supply chain problems cut into its near-term outlook and sent the shares down about 10% in early trading. We are reducing our 2022 and 2023 expectations based on the headwinds Baxter's operations are facing, which has cut our fair value estimate to $85 per share from $90. The shares appear significantly undervalued at recent levels.